Poket News

CSIR gets nod for Phase III trial of antiviral drug Umifenovir: Health Minister


  • Health and Family Welfare Minister Dr. Harsh Vardhan on 19 June said that Council for Scientific and Industrial Research constituent lab Central Drug Research Institute, Lucknow has received permission for carrying out Phase III randomized, double-blind, placebo-controlled trial of efficacy, safety and tolerability of antiviral drug Umifenovir.
  • He said, the Phase III clinical trials will be carried out at King George's Medical University, Dr Ram Manohar Lohia Institute of Medical Sciences and ERA's Lucknow Medical College and Hospital.